Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
about
The physiological determinants of sudden infant death syndrome.A sigh of relief or a sigh of expected relief: Sigh rate in response to dyspnea relief.Severe respiratory dysrhythmia in Rett syndrome treated with topiramate.Modulation of respiratory output by cervical epidural stimulation in the anesthetized mouse.The "other" respiratory effect of opioids: suppression of spontaneous augmented ("sigh") breaths.
P2860
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@en
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@nl
type
label
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@en
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@nl
prefLabel
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@en
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@nl
P2860
P1476
Acetazolamide suppresses the prevalence of augmented breaths during exposure to hypoxia.
@en
P2093
Harold J Bell
Philippe Haouzi
P2860
P304
P356
10.1152/AJPREGU.00126.2009
P577
2009-06-03T00:00:00Z